期刊文献+

处方中不合理用药的典型实例分析 被引量:3

Typical case analysis of illegitimate drug using in prescriptions
下载PDF
导出
摘要 目的调查本院门急诊处方用药情况,为临床合理用药提供参考。方法随机抽取本院2012年1~9月门急诊处方,根据《医院处方点评管理规范》(试行)的相关规定,对各类不合理情况进行调查分析和点评。结果不合理问题包括重复用药、无指征用药、单次剂量过大、每日给药次数过少、药物联用不合理现象。结论高质量的处方点评可以提高医师和药师的用药水平,药师应为临床提供及时的最新用药信息,协助医师提高合理用药水平。 Objective To research the medication status of prescriptions in outpatient and emergency department, so as to provide references of legitimate drug using in clinical trails. Methods Prescriptions in outpatient department from January to September 2012 were randomly chosen and analyzed and commented for various illegitimate conditions ac cording to the relevant provisions of the "Management Review of Hospital Prescriptions" (Trial). Results Illegitimate conditions included repeated medicine use, no indications of medicine use, single medicine overdose, insufficient of the times of daily dosing, problems in drug combinations. Conclusion High quality of comments on prescriptions can enhance physicians' and pharmacists' medication levels. Pharmacists should offer cutting edge medication information to doctors and assist doctors in legitimate use of drugs.
作者 张湛
出处 《中国当代医药》 2013年第3期183-184,共2页 China Modern Medicine
关键词 门急诊处方 处方点评 合理用药 分析 Outpatient and emergency departments' prescription Comments on prescriptions Legitimate drug using Analysis
  • 相关文献

参考文献6

二级参考文献33

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:788
  • 3钟洪兰,郭粤霞,黄华英,谢东旭.点评问题处方 促进合理用药[J].现代医院,2007,7(2):121-122. 被引量:15
  • 4Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 5de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 6Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
  • 7Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.
  • 8Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.
  • 9Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.
  • 10Mandell LA,Bartlett JG,Dowell SF,et al.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Clin Infect Dis,2003,37:1405-1433.

共引文献3080

同被引文献18

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部